|
VNDA Vanda Pharmaceuticals Inc. 1347178 |
| Balance Sheet |
|
Current Assets
|
$264,484,000.00 |
|
Assets
|
$412,467,000.00 |
|
Current Liabilities
|
$164,026,000.00 |
|
Liabilities
|
$192,282,000.00 |
|
Equity
|
$220,185,000.00 |
|
Shares Out
|
60454687.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-81,288,000.00 |
|
Investing Cash Flow
|
$54,044,000.00 |
| Market Analysis |
Market Cap
|
$325,246,216.06 |
|
Price
|
$5.38 |
|
BVPS
|
3.64 |
|
PB
|
1.48 |
|
EPS
|
-1.04 |
|
PS
|
1.61 |
|
FCF
|
$-81,699,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:42 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:33 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-11 |
-2.39 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-06 |
-0.82 |
|
| Jul |
Aug |
Sep |
|
|
2025-07-31 |
-0.46 |
|
|
|
| Oct |
Nov |
Dec |
|
|
2025-10-29 |
-0.38 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VNDA documents filed with the SEC.
VNDA Filings
Clear
